WallStSmart

SBC Medical Group Holdings Incorporated (SBC)vsSpace Exploration Technologies Corp. Class A Common Stock (SPCX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Space Exploration Technologies Corp. Class A Common Stock generates 13055% more annual revenue ($23.04B vs $175.17M). SBC leads profitability with a 28.0% profit margin vs -35.7%. SBC earns a higher WallStSmart Score of 72/100 (B).

SBC

Strong Buy

72

out of 100

Grade: B

Growth: 6.0Profit: 9.0Value: 6.3Quality: 8.5
Piotroski: 2/9Altman Z: 3.94

SPCX

Avoid

30

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 6.0
Piotroski: 3/9Altman Z: 0.17

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SBC6 strengths · Avg: 9.7/10
P/E RatioValuation
8.6x10/10

Attractively priced relative to earnings

Operating MarginProfitability
38.6%10/10

Strong operational efficiency at 38.6%

EPS GrowthGrowth
338.9%10/10

Earnings expanding 338.9% YoY

Altman Z-ScoreHealth
3.9410/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
28.0%9/10

Keeps 28 of every $100 in revenue as profit

Debt/EquityHealth
0.189/10

Conservative balance sheet, low leverage

SPCX2 strengths · Avg: 10.0/10
Market CapQuality
$1.95T10/10

Mega-cap, among the largest globally

Revenue GrowthGrowth
91.9%10/10

Revenue surging 91.9% year-over-year

Areas to Watch

SBC3 concerns · Avg: 3.3/10
PEG RatioValuation
1.644/10

Expensive relative to growth rate

Market CapQuality
$423.73M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

SPCX4 concerns · Avg: 3.3/10
Price/BookValuation
15.7x4/10

Trading at 15.7x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-5.0%2/10

ROE of -5.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : SBC

The strongest argument for SBC centers on P/E Ratio, Operating Margin, EPS Growth. Profitability is solid with margins at 28.0% and operating margin at 38.6%. Revenue growth of 13.4% demonstrates continued momentum.

Bull Case : SPCX

The strongest argument for SPCX centers on Market Cap, Revenue Growth. Revenue growth of 91.9% demonstrates continued momentum.

Bear Case : SBC

The primary concerns for SBC are PEG Ratio, Market Cap, Piotroski F-Score.

Bear Case : SPCX

The primary concerns for SPCX are Price/Book, EPS Growth, Piotroski F-Score.

Key Dynamics to Monitor

SBC profiles as a mature stock while SPCX is a hypergrowth play — different risk/reward profiles.

SPCX is growing revenue faster at 91.9% — sustainability is the question.

SBC generates stronger free cash flow (22M), providing more financial flexibility.

Monitor CONSULTING SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SBC scores higher overall (72/100 vs 30/100), backed by strong 28.0% margins and 13.4% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

SBC Medical Group Holdings Incorporated

INDUSTRIALS · CONSULTING SERVICES · USA

SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.

Visit Website →

Space Exploration Technologies Corp. Class A Common Stock

INDUSTRIALS · AEROSPACE & DEFENSE · USA

Space Exploration Technologies Corp. The company is headquartered in Starbase, Texas.

Want to dig deeper into these stocks?